Lotilaner

Lotilaner is a member of the class of isoxazoles that is 4,5-dihydro-1,2-oxazole substituted by 4-methyl-5-({2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}carbamoyl)thiophen-2-yl, trifluoromethyl, and 3,4,5-trichlorophenyl groups at positions 3, 5 and 5, respectively (the 5S-stereoisomer). It is a gamma-aminobutyric acid (GABA)-gated chloride channel inhibitor selective for mites, approved for the treatment of Demodex blepharitis. Among its listed roles, it functions as a GABA-gated chloride channel antagonist, an ophthalmology drug and an ectoparasiticide. It is a trichlorobenzene, a member of isoxazoles, an organofluorine compound, a member of thiophenes and a secondary carboxamide. It is grouped under the following drug class(es): Ectoparasiticides. Its therapeutic use is listed as antiparasitics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Credelio and lotilanerum. Its PubChem CID is 76959255.

CAS No 1369852-71-0
Molecular Formula C20H14Cl3F6N3O3S
Molecular Weight 596.80 g/mol
Synonyms 3-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]thiophene-2-carboxamide

Frequently Asked Questions